Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of Heart Rate on Central Hemodynamics During Antihypertensive Therapy
2011-006090-25Phase 4Completed
- Sponsor
- Tartu University Hospital Cardiology Clinic
- Start
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of ivabradine, nebivolol and atenolol in hypertension (HTN) and sick sinus syndrome (SSS) (3 arms), sponsored by Tartu University Hospital Cardiology Clinic. Primary endpoint: Change in central aortic blood pressure. Started Dec 2011; status: completed.
02
Drugs
ivabradinenebivololatenolol
03
Conditions
hypertension (HTN)sick sinus syndrome (SSS)
Beyond the preview
Go deeper on 2011-006090-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-006090-25.